-
1
-
-
84867578956
-
Characterization of a NNRTI, UK-453,061 in vitro
-
Boston
-
Mori J, Corbau R, Lewis D, Ellery S, Mayer H, Perros M, Westby M (2008) Characterization of a NNRTI, UK-453,061 in vitro. In: 15th Conf Retroviruses and Opportunistic Infections (abstract 728). Boston
-
(2008)
15th Conf Retroviruses and Opportunistic Infections (Abstract 728)
-
-
Mori, J.1
Corbau, R.2
Lewis, D.3
Ellery, S.4
Mayer, H.5
Perros, M.6
Westby, M.7
-
2
-
-
84867575363
-
Efficacy and safety of lersivirine vs efavirenz in antiretroviral treatment-naive HIV-1-infected patients: Week 48 primary analysis results from an ongoing multicentre, randomised, double-blind, Phase IIIb trial (Study A5271015)
-
Rome
-
Vernazza P, Wang C, Pozniak A, Weil E, Pulik P, Cooper DA, Kaplan R, Lazzarin A, Valdez H, Goodrich J, Craig C, Mori J, Tawadrous M (2011) Efficacy and safety of lersivirine vs efavirenz in antiretroviral treatment-naive HIV-1-infected patients: Week 48 primary analysis results from an ongoing multicentre, randomised, double-blind, Phase IIIb trial (Study A5271015). In: 16th Int AIDS Conf on HIV Pathogenesis, Treatment and Prevention (abstract TUAB0101). Rome
-
(2011)
16th Int AIDS Conf on HIV Pathogenesis, Treatment and Prevention (Abstract TUAB0101)
-
-
Vernazza, P.1
Wang, C.2
Pozniak, A.3
Weil, E.4
Pulik, P.5
Cooper, D.A.6
Kaplan, R.7
Lazzarin, A.8
Valdez, H.9
Goodrich, J.10
Craig, C.11
Mori, J.12
Tawadrous, M.13
-
3
-
-
77950920638
-
14C]Lersivirine to healthy volunteers
-
20124396 10.1124/dmd.109.031252
-
14C] Lersivirine to healthy volunteers. Drug Metab Dispos 38:789-800
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 789-800
-
-
Vourvahis, M.1
Gleave, M.2
Nedderman, A.N.R.3
Hyland, R.4
Gardner, I.5
Howard, M.6
Kempshall, S.7
Collins, C.8
Labadie, R.9
-
4
-
-
84867582732
-
The effect of UK-453,061, a next-generation NNRTI, on the steady state pharmacokinetics of zidovudine, midazolam and contraceptive steroids
-
New Orleans
-
Davis J, Langdon G, Layton G, Chong C, Ndongo M-N, Weissgerber G, Vourvahis M (2008) The effect of UK-453,061, a next-generation NNRTI, on the steady state pharmacokinetics of zidovudine, midazolam and contraceptive steroids. In: 9th Int Workshop on Clinical Pharmacology of HIV Therapy (poster P25). New Orleans
-
(2008)
9th Int Workshop on Clinical Pharmacology of HIV Therapy (Poster P25)
-
-
Davis, J.1
Langdon, G.2
Layton, G.3
Chong, C.4
Ndongo, M.-N.5
Weissgerber, G.6
Vourvahis, M.7
-
5
-
-
79955690629
-
-
European Medicines Agency
-
European Medicines Agency (2010) Guideline on the investigation of drug interactions. Available at: http://www.ema.europa.eu/docs/en-GB/document- library/Scientific-guideline/2010/05/WC500090112.pdf
-
(2010)
Guideline on the Investigation of Drug Interactions
-
-
-
6
-
-
69849107159
-
Clinical pharmacokinetics and pharmacodynamics of etravirine
-
19725591 10.2165/10895940-000000000-00000
-
Schöller-Gyüre M, Kakuda TN, Raoof A, de Smedt G, Hoetelmans RM (2009) Clinical pharmacokinetics and pharmacodynamics of etravirine. Clin Pharmacokinet 48:561-574
-
(2009)
Clin Pharmacokinet
, vol.48
, pp. 561-574
-
-
Schöller-Gyüre, M.1
Kakuda, T.N.2
Raoof, A.3
De Smedt, G.4
Hoetelmans, R.M.5
-
7
-
-
21544472342
-
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: Results of AIDS Clinical Trials Group 5108 study
-
DOI 10.1097/01.qai.0000167156.44980.33
-
Gerber JG, Rosenkranz SL, Fichtenbaum CJ, Vega JM, Yang A, Alston BL, Brobst SW, Segal Y, Aberg JA (2005) Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. J Acquir Immune Defic Syndr 39:307-312 (Pubitemid 40923210)
-
(2005)
Journal of Acquired Immune Deficiency Syndromes
, vol.39
, Issue.3
, pp. 307-312
-
-
Gerber, J.G.1
Rosenkranz, S.L.2
Fichtenbaum, C.J.3
Vega, J.M.4
Yang, A.5
Alston, B.L.6
Brobst, S.W.7
Segal, Y.8
Aberg, J.A.9
-
8
-
-
42149117406
-
The recovery time-course of CYP3A after induction by St John's wort administration
-
DOI 10.1111/j.1365-2125.2008.03120.x
-
Imai H, Kotegawa T, Tsutsumi K, Morimoto T, Eshima N, Nakano S, Ohashi K (2008) The recovery time-course of CYP3A after induction by St John's wort administration. Br J Clin Pharmacol 65:701-707 (Pubitemid 351535099)
-
(2008)
British Journal of Clinical Pharmacology
, vol.65
, Issue.5
, pp. 701-707
-
-
Imai, H.1
Kotegawa, T.2
Tsutsumi, K.3
Morimoto, T.4
Eshima, N.5
Nakano, S.6
Ohashi, K.7
-
9
-
-
0034748331
-
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity
-
DOI 10.1067/mcp.2001.118522
-
Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD (2001) The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 70:317-326 (Pubitemid 33022472)
-
(2001)
Clinical Pharmacology and Therapeutics
, vol.70
, Issue.4
, pp. 317-326
-
-
Wang, Z.1
Gorski, J.C.2
Hamman, M.A.3
Huang, S.-M.4
Lesko, L.J.5
Hall, S.D.6
-
10
-
-
0042950000
-
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects
-
DOI 10.1067/mcp.2003.10
-
Dresser GK, Schwarz UI, Wilkinson GR, Kim RB (2003) Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Ther 73:41-50 (Pubitemid 36158485)
-
(2003)
Clinical Pharmacology and Therapeutics
, vol.73
, Issue.1
, pp. 41-50
-
-
Dresser, G.K.1
Schwarz, U.I.2
Wilkinson, G.R.3
Kim, R.B.4
-
11
-
-
84867570996
-
Pharmacokinetic interaction study between TMC278, an NNRTI, and the contraceptives norethindrone plus ethinylestradiol
-
Crauwels HM, Van Heeswijk RPG, Cornelis L, McNeeley D, Buelens A, Clark A, Boven K, Hoetelmans RMW (2009) Pharmacokinetic interaction study between TMC278, an NNRTI, and the contraceptives norethindrone plus ethinylestradiol. HIV Med 10:82
-
(2009)
HIV Med
, vol.10
, pp. 82
-
-
Crauwels, H.M.1
Van Heeswijk, R.P.G.2
Cornelis, L.3
McNeeley, D.4
Buelens, A.5
Clark, A.6
Boven, K.7
Hoetelmans, R.M.W.8
-
12
-
-
84875054867
-
Sustiva 600 mg film-coated tablets, Summary of Product Characteristics
-
Bristol-Myers Squibb Pharmaceuticals Ltd Accessed 29 Oct 2010
-
Bristol-Myers Squibb Pharmaceuticals Ltd (2010) Sustiva 600 mg film-coated tablets, Summary of Product Characteristics. Electronic Medicines Compendium. Available at: http://www.medicines.org.uk/EMC/medicine/11284/SPC/ Sustiva+600+mg+Film-Coated+Tablets/. Accessed 29 Oct 2010
-
(2010)
Electronic Medicines Compendium
-
-
-
13
-
-
66549114704
-
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone
-
19501215 10.1016/j.contraception.2009.01.009
-
Schöller-Gyüre M, Kakuda TN, Woodfall B, Aharchi F, Peeters M, Vandermeulen K, Hoetelmans RM (2009) Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone. Contraception 80:44-52
-
(2009)
Contraception
, vol.80
, pp. 44-52
-
-
Schöller-Gyüre, M.1
Kakuda, T.N.2
Woodfall, B.3
Aharchi, F.4
Peeters, M.5
Vandermeulen, K.6
Hoetelmans, R.M.7
-
14
-
-
84867575371
-
The effect of UK-453,061, a next-generation NNRTI, on the steady-state pharmacokinetics of maraviroc, a CCR5 antagonist
-
Rev Antiviral Ther 3:P27
-
Langdon G, Davis J, Layton G, Ndongo M-N, Vourvahis M (2008) The effect of UK-453,061, a next-generation NNRTI, on the steady-state pharmacokinetics of maraviroc, a CCR5 antagonist. In: 9th Int Workshop on Clinical Pharmacology of HIV Therapy (abstract). Rev Antiviral Ther 3:P27
-
(2008)
9th Int Workshop on Clinical Pharmacology of HIV Therapy (Abstract)
-
-
Langdon, G.1
Davis, J.2
Layton, G.3
Ndongo, M.-N.4
Vourvahis, M.5
-
15
-
-
84875054409
-
-
ViiV Healthcare Accessed 24 June 2011
-
ViiV Healthcare (2009) Selzentry (maraviroc) prescribing information. Available at: http://www.selzentry.com/. Accessed 24 June 2011
-
(2009)
Selzentry (Maraviroc) Prescribing Information
-
-
-
16
-
-
33644904320
-
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects
-
DOI 10.1111/j.1365-2125.2005.02539.x
-
Sidhu J, Job S, Singh S, Philipson R (2006) The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 61:191-199 (Pubitemid 43382612)
-
(2006)
British Journal of Clinical Pharmacology
, vol.61
, Issue.2
, pp. 191-199
-
-
Sidhu, J.1
Job, S.2
Singh, S.3
Philipson, R.4
|